Quantum Mechanics of Biological Systems
暫譯: 生物系統的量子力學

《生物系統的量子力學》是一個不斷發展的生物學領域，利用量子力學原則來解決關鍵的生物過程。這個領域不僅揭示了分子生物學中活躍的基本機制，還幫助我們將這些資訊轉化為應用於醫學研究的成果，旨在發現應對各種病理學分子層面起源的方法。本書首先簡要回顧量子生物學的歷史，接著探討量子力學方法在解決疾病的分子基礎和藥物發現方面所取得的重大突破。本書中包括了有關中子散射在蛋白質能量景觀中的作用、光合作用光譜的建模、生命的量子過程，以及食品科學的量子和時間理論的章節。此外，還討論了對遺傳相關性和進化的量子力學理解。本書也提供了量子生物學發展的歷史。本書將吸引本科生和研究生，以及在物理學、化學、生物化學、數學、腫瘤學、生物資訊學、生物醫學工程、電機工程、醫學、藥理學和生物學等領域工作的學者。

主要特點：
- 探索不斷增長且令人興奮的新興跨學科領域 QMBS。
- 包含來自世界領先專家的章節貢獻。
- 討論量子力學方法在生物醫學研究中的影響。

Mohammad Ashrafuzzaman, D.Sc., a biophysicist and condensed matter scientist, is passionate about investigating biological and biochemical processes utilizing principles and techniques of physics. His theoretical and experimental works have created a generalized template to address the membrane and protein interactions of cell-targeted agents, including drugs and nanoparticles. He has generalized the screened Coulomb interaction method to apply in biological systems and has developed a set of techniques (patented) to help design novel drug molecules, including especially aptamers, validate the drugs' biological target binding potency, and help address the drug efficacy against specific diseases. His outstanding impact in biomedical sciences has ensured creating a new dimension in drug discovery using physics techniques. Before joining (current affiliation) the King Saud University's Biochemistry Department of College of Science, Riyadh, Saudi Arabia, he held academic ranks at Bangladesh University of Engineering and Technology, Neuchatel University (Switzerland), Helsinki University of Technology (Finland), Cornell University (United States), and Alberta University (Canada). Between 2013 and 2018 Prof. Ashrafuzzaman worked at the departments of Oncology and Medical Microbiology & Immunology, University of Alberta (Canada) as a Visiting Professor. He is the co-founder of MDT Canada Inc., and the founder of Child Life Development Institute, Edmonton, Canada. Besides publishing many peer-reviewed articles and 3 US patents, he is currently serving on editorial boards of several highly reputed journals. He has already authored several textbooks, such as Introduction to Modern Biophysics, Biophysics and Nanotechnology of Ion Channels, Nanoscale Biophysics of the Cell, and Membrane Biophysics, including and a few in progress. Prof. Ashrafuzzaman obtained Doctor of Science (D.Sc.) from University of Neuchatel, Switzerland in 2004 following his graduation (B.Sc. and M.Sc.) from Dhaka University, Bangladesh.

Jack A. Tuszynski holds the position of professore ordinario (Full Professor) in biomedical engineering at the Politecnico di Torinoin Turin, Italy. Between 2005 and 2020 he served as the inaugural Allard Chair and Professor in Experimental Oncology at the Cross Cancer Institute and since 1988 has been a professor in the Department of Physics at the University of Alberta, Edmonton, Canada. He was also a Fellow of the National Institute for Nanotechnology of Canada. He held visiting professorship in China, Germany, France, Israel, Denmark, Belgium, Poland and Switzerland. Jack Tuszynski heads a multi-disciplinary team focused on the rational drug design for oncology, neurology, and immunology applications using computational biophysics and bioengineering methods. His group is also developing physiologically-based models and simulations for pharmacokinetic and pharmacodynamic applications. More recently, he has been involved in the studies of electromagnetic interaction with biological systems developing novel non-pharmacological therapies in collaboration with several companies in Canada, US and Switzerland. He has published over 600 journal papers, and 12 books. He obtained 7 patents in the USA, Canada, EU, South Korea, Brazil, Japan and Singapore. He received over 100 research grants from Canadian, US and European funding agencies. He is on the editorial board of 30 international journals. He was a founding member of 3 spin-off companies.

Mohammad Ashrafuzzaman, D.Sc. 是一位生物物理學家和凝聚態科學家，熱衷於利用物理學的原則和技術研究生物和生化過程。他的理論和實驗工作創建了一個通用模板，以解決細胞靶向劑（包括藥物和納米顆粒）的膜和蛋白質相互作用。他已將篩選的庫倫相互作用方法推廣到生物系統中，並開發了一套技術（已獲專利），以幫助設計新型藥物分子，特別是適體，驗證藥物的生物靶點結合效能，並幫助解決藥物對特定疾病的療效。他在生物醫學科學方面的卓越影響力，確保了利用物理技術創造藥物發現的新維度。在加入（目前所屬）沙烏地阿拉伯利雅德的國王沙烏德大學科學學院生物化學系之前，他曾在孟加拉工程科技大學、瑞士納沙泰爾大學、芬蘭赫爾辛基科技大學、美國康奈爾大學和加拿大阿爾伯塔大學擔任學術職位。2013年至2018年間，Ashrafuzzaman教授在加拿大阿爾伯塔大學的腫瘤學及醫學微生物學與免疫學系擔任訪問教授。他是MDT Canada Inc.的共同創辦人，也是加拿大埃德蒙頓的兒童生命發展研究所的創始人。除了發表許多同行評審的文章和3項美國專利外，他目前還擔任幾本知名期刊的編輯委員會成員。他已經撰寫了幾本教科書，如現代生物物理學導論、離子通道的生物物理學與納米技術、細胞的納米尺度生物物理學和膜生物物理學，以及一些正在進行中的作品。Ashrafuzzaman教授於2004年在瑞士納沙泰爾大學獲得科學博士學位（D.Sc.），之前在孟加拉達卡大學獲得學士和碩士學位。

Jack A. Tuszynski 擔任意大利都靈理工大學生物醫學工程的全職教授（professore ordinario）。在2005年至2020年間，他擔任了跨癌症研究所的首任Allard講座教授和實驗腫瘤學教授，自1988年以來一直是加拿大埃德蒙頓阿爾伯塔大學物理系的教授。他還曾是加拿大國家納米技術研究所的研究員。他在中國、德國、法國、以色列、丹麥、比利時、波蘭和瑞士擔任過訪問教授。Jack Tuszynski領導一個多學科團隊，專注於使用計算生物物理學和生物工程方法進行腫瘤學、神經學和免疫學應用的理性藥物設計。他的團隊還在開發生理基礎模型和模擬，用於藥物動力學和藥效學應用。最近，他參與了與生物系統的電磁相互作用研究，並與加拿大、美國和瑞士的幾家公司合作開發新型非藥物療法。他已發表超過600篇期刊論文和12本書籍。在美國、加拿大、歐盟、南韓、巴西、日本和新加坡獲得了7項專利。他從加拿大、美國和歐洲的資助機構獲得了超過100項研究資助。他是30本國際期刊的編輯委員會成員，也是3家衍生公司的創始成員。